Polymerase Chain Reaction Technologies Market Research, 2030
The global polymerase chain reaction technologies market was valued at $16.7 billion in 2020, and is projected to reach $28.8 billion by 2030, growing at a CAGR of 4.1% from 2021 to 2030. Polymerase chain reaction (PCR) is a significant logical method in the molecular biology science that enhances single or scarcely any duplicates of a piece of DNA. Likewise, it is useful in creating thousands to millions of duplicates of a specific DNA grouping and exploring illnesses such as AIDS, tuberculosis, Lyme sickness, and middle ear diseases. The innovation includes three significant advances denaturation, toughening, and expansion. It is pertinent in clinical, research, clinical diagnostics, and legal sciences. It has been used since a very long time as a standard technique for research on nucleic acids (RNA and DNA) in labs. PCR available the polymerase chain reaction technologies market are continuous quantitative (qPCR), computerized PCR (dPCR), converse PCR, multiplex PCR, gathering PCR, and standard PCR. The need of powerful demonstrative diagnostic methods in medical care to recognize illnesses energizes the interest for the development of the polymerase chain reaction (PCR) technologies market.
Development in occurrence of malignant growth and irresistible infection drive the polymerase chain response innovations market. For instance, cancer is one of the main reasons of death across the globe. According to the National Cancer Institute, many individuals suffer with cancer due to contamination. Owing to the ascent in the quantity of patients experiencing constant infections, there is expected to be an expansion in the interest in polymerase chain reaction technologies market advancements for early analysis of illnesses. Henceforth, different association starts with the treatment at the earliest, with the expansion in the pervasiveness of the sicknesses, around the world. There is an expansion in the interest in PCR innovations to recognize these sicknesses at the beginning phases. Hence this positively impacts the development of the market. In addition, the progressions in PCR advances by key part in industry help the development of the market by making progressed items accessible to the medical services experts for recognition of different sorts of irresistible sicknesses, malignant growth, blood screening, and different applications, which drive the growth of the polymerase chain reaction technologies market size.
However, PCR tests can be utilized for the analysis of different infections. In any case, the expense related with the utilization of PCR advancements for the symptomatic tests are high. Subsequently, patients do not opt for such tests. Likewise, numerous nations do not give repayment to these tests. The execution of these rates would bring about decrease in repayment for key molecular tests, including inherited disease, molecular cytogenetics, and cancer testing. Henceforth, absence of repayments facility further hinders the polymerase chain reaction technologies market growth.
By Technology
RT-PCR holds the largest share in themarket owing to large scale testing for COVID during the pandamic
Furthermore, during the outbreak of the COVID-19 pandemic, construction, manufacturing, hotel, and tourism industries were majorly affected. Manufacturing activities were halted or restricted. Construction and transportation activities, along with their supply chains, were hampered on a global level. However the polymerase chain reaction technologies market tremendously rose due to testing of COVID tests.
By Product
Services is the fastest growing segment owing to rise in usage of PCR amongs people
On the contrary, the rise in the occurrence of the infectious diseases such as cancer and infection has increased the demand of the indicative methods that could help in the early recognition of these infections. This has prompted an expansion in subsidizing for the R&D activities that could help in the early finding of these infections. In addition, significant organizations put resources into the headway of the molecular diagnostics, for instance, PCR, which is anticipated to boost development and demand in the field. The expansion in subsidizing for R&D exercises that incorporates the utilization of PCR for different purposes could expand the utilization of these advances and could accordingly offer new opportunities in the polymerase chain reaction technologies market.
By End Users
Dianostic centers and hospitals held largest share in the market owing to usage of PCR tests for COVID around the world
The polymerase chain reaction technologies market share is segmented on the basis of technology, product, application, end user industry, and region. By technology, the market is divided intoreal-time PCR, traditional PCR, and digital PCR. By product, the market is segmented into reagents & consumables, instruments, software, and services. By end user, the market is fragmented into diagnostic centers & hospitals, biotech & pharma companies, and academic & research institutions. Region wise, the global polymerase chain reaction technologies market analysis is conducted across North America (the U.S., Canada, and Mexico), Europe (the UK, France, Germany, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).
On the basis of technology, in 2020, the real-time PCR segment dominated the polymerase chain reaction industry, in terms of revenue, whereas the digital PCR segment is expected to witness growth at the highest CAGR during the forecast period. As per product, in 2020, the reagents & consumables segment led the Polymerase chain reaction technology market; however, the software segment is expected to exhibit highest CAGR in the near future. Region wise, Asia-Pacific garnered the highest revenue in 2020; however, LAMEA is anticipated to register highest CAGR during the polymerase chain reaction technologies market forecast period.
The major players profiled in the polymerase chain reaction technologies market include Abcam plc. (Expedeon AG), Agilent Technologies, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc. , F. Hoffmann-La Roche Ltd , Fluidigm , LGC Limited , Qiagen, Takara Bio Inc. , Thermo Fisher Scientific Inc. Major companies in the market have adopted product launch, partnership, and agreement as their key developmental strategies to offer better products and services to customers in the Polymerase chain reaction technology market.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the polymerase chain reaction technologies market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the polymerase chain reaction technologies market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global polymerase chain reaction technologies market trends, key players, market segments, application areas, and market growth strategies.
Polymerase Chain Reaction Technologies Market Report Highlights
| Aspects | Details |
 By End Users |
|
 By Technology |
|
 By Product |
|
 By Region |
|
 Key Market Players | AGILENT TECHNOLOGIES, BIO-RAD LABORATORIES, FLUIDIGM CORPORATION, LGC LIMITED, THERMO FISHER SCIENTIFIC INC, QIAGEN N.V, SYGNIS AG, TAKARA BIO INC, F. HOFFMANN-LA ROCHE AG (ROCHE), BIOMERIEUX S.A |
Analyst Review
The demand for polymerase chain reaction technologies is on a rapid increase. Polymerase chain reaction (PCR) is one of the revolutionary technologies that was earlier used in research institutions, pharmaceutical, and biotechnology industries. However, due to the advancement in technology, PCR can help to precisely diagnose life-threatening diseases such as cancer and Ebola, which boosts the popularity and usage of PCR in the commercial diagnostic laboratories and hospitals. The market is expected to observe a steady growth owing to the expansion in its application areas and increased accuracy & precision. Moreover, the advantages of using PCR technologies such as digital PCR (dPCR) and real-time PCR (qPCR) such as real-time process monitoring, low reagent consumption, automation of workflow, and greater reproducibility & precision. There is a rise in the number of acquisition of standalone laboratories with minimal infrastructure in less developed areas by multi-chain diagnostic laboratories due to expected increase in the demand for diagnostics techniques in these regions. A strong demand for compact and portable PCR with high reliability and sensitivity along with high affordability has been witnessed. These advanced features help provide lucrative growth opportunities for PCR market. Among the technology segment, dPCR is the fastest-growing segment in the market. The segment is expected to witness the highest CAGR during the forecast period due to the surge in government and private funding for gene-based research, the development of innovative dPCR devices, and high growth opportunities in emerging countries.
The global polymerase chain reaction technologies market size was $16,669.3 million in 2020, and is expected to reach $28,755.1 million by 2030, with a CAGR of 4.1% from 2021 to 2030.
The forecast period considered for the global polymerase chain reaction technologies market is 2021 to 2030, wherein, 2020 is the base year, 2021 is the estimated year, and 2030 is the forecast year.
To get latest version of global polymerase chain reaction technologies market report can be obtained on demand from the website.
The top companies holding the market share in the global polymerase chain reaction technologies market report include Abcam plc. (Expedeon AG), Agilent Technologies, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc. , F. Hoffmann-La Roche Ltd , Fluidigm , LGC Limited , Qiagen, Takara Bio Inc. , Thermo Fisher Scientific Inc.
By technology, the RT=PCR segment dominated the global polymerase chain reaction technologies market, in terms of revenue and is expected to maintain this trend during the forecast period.
The report contains an exclusive company profile section, where leading 10 companies in the market are profiled. These profiles typically cover company overview, geographical presence, market dominance (in terms of revenue and volume sales), various strategies and recent developments.
Loading Table Of Content...
